Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
US Army
Argus Health
UBS
Fish and Richardson
Covington
Chinese Patent Office
Boehringer Ingelheim
Novartis
Citi

Generated: October 21, 2017

DrugPatentWatch Database Preview

Indomethacin - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for indomethacin and what is the scope of indomethacin patent protection?

Indomethacin
is the generic ingredient in six branded drugs marketed by Sun Pharm Inds, Glenmark Pharms Ltd, Sun Pharm Inds Inc, Zydus Pharms Usa Inc, Jubilant Generics, Parke Davis, Hetero Labs Ltd Iii, Inwood Labs, Cycle Pharms Ltd, Pioneer Pharms, Able, Iroko Pharms, G And W Labs, Ivax Sub Teva Pharms, Mylan, Duramed Pharms Barr, Chartwell Rx, Chartwell Molecules, Watson Labs, Halsey, Fresenius Kabi Usa, Mylan Pharms Inc, Teva, Aurobindo Pharma Ltd, Pliva, Amneal Pharms, Heritage Pharms Inc, Novast Labs Ltd, Iroko Pharms Llc, Sandoz, Mutual Pharm, Watson Labs Inc, Avanthi Inc, Glenmark Generics, Superpharm, West-ward Pharms Int, Hospira Inc, Navinta Llc, and Recordati Rare, and is included in seventy NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Indomethacin has thirty-five patent family members in twenty countries.

There are fifteen drug master file entries for indomethacin. Fifty-four suppliers are listed for this compound.

Summary for Generic Name: indomethacin

US Patents:3
Tradenames:6
Applicants:39
NDAs:70
Drug Master File Entries: see list15
Suppliers / Packagers: see list54
Bulk Api Vendors: see list108
Clinical Trials: see list119
Patent Applications: see list8,887
Therapeutic Class:Anti-inflammatory Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:indomethacin at DailyMed

Pharmacology for Ingredient: indomethacin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Superpharm
INDOMETHACIN
indomethacin
CAPSULE;ORAL070488-001Oct 10, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
INDOMETHACIN
indomethacin
CAPSULE;ORAL018690-002Jul 31, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Hospira Inc
INDOMETHACIN SODIUM
indomethacin sodium
INJECTABLE;INJECTION204118-001Apr 19, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
Glenmark Pharms Ltd
INDOMETHACIN
indomethacin
CAPSULE, EXTENDED RELEASE;ORAL203501-001Jun 22, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Chartwell Molecules
INDOMETHACIN
indomethacin
CAPSULE;ORAL070651-001Mar 5, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Iroko Pharms
INDOCIN SR
indomethacin
CAPSULE, EXTENDED RELEASE;ORAL018185-001Feb 23, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds
INDOMETHACIN
indomethacin
CAPSULE;ORAL070900-001Feb 9, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz
INDOMETHACIN
indomethacin
CAPSULE;ORAL070673-001Apr 29, 1987ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva
INDO-LEMMON
indomethacin
CAPSULE;ORAL070267-001Nov 7, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Chartwell Rx
INDOMETHACIN
indomethacin
CAPSULE, EXTENDED RELEASE;ORAL200529-001Nov 30, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: indomethacin

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Iroko Pharms
INDOCIN
indomethacin
SUPPOSITORY;RECTAL017814-001Aug 13, 1984► Subscribe► Subscribe
Iroko Pharms
INDOCIN SR
indomethacin
CAPSULE, EXTENDED RELEASE;ORAL018185-001Feb 23, 1982► Subscribe► Subscribe
Iroko Pharms
INDOCIN
indomethacin
SUPPOSITORY;RECTAL017814-001Aug 13, 1984► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: indomethacin

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,095,496Formulation of indomethacin► Subscribe
9,522,135Formulation of indomethacin► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: indomethacin

Country Document Number Estimated Expiration
Australia2010239081► Subscribe
South Korea101743847► Subscribe
World Intellectual Property Organization (WIPO)2010121328► Subscribe
Tunisia2011000544► Subscribe
Morocco33296► Subscribe
South Korea20140077945► Subscribe
Mexico2011011226► Subscribe
New Zealand595986► Subscribe
Japan6043329► Subscribe
African Regional IP Organization (ARIPO)201508955► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Chinese Patent Office
Moodys
McKesson
Fuji
Express Scripts
Fish and Richardson
Teva
Julphar
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot